Join

Enter Details

Comment on stories, receive email newsletters & alerts.

@
This is your permanent identity for Business Insider Australia
Your email must be valid for account activation
Minimum of 8 standard keyboard characters

Subscribe

Email newsletters but will contain a brief summary of our top stories and news alerts.

Forgotten Password

Enter Details


Back to log in

Tagged With Biotech

One in 7 people in Nevada is living with diabetes, and the state is now pushing a new approach to tackle the cost of treatment


Google's venture capital arm has backed a startup spun out of Oxford that is developing 'biotech superglue'


A small drug company that's trying to make cancer treatments safer just received a huge endorsement


A 29-year-old founded a biotech startup to cure rare cancers after he got a life-changing diagnosis


Biotech is speaking out against Trump's immigration ban


A new study could change the way we treat brain tumours


'The outlier thing didn't work out' -- Biotech CEOs reflect on Theranos' impact on the industry


A Japanese drug giant and a tiny New York biotech are teaming up in an unprecedented way


The tiny Australia biotech benefiting from its links to Donald Trump


A woman in the US just died from a bug that resisted 26 antibiotics -- here's why it's so hard to develop new ones



Donald Trump just took the joy out of the drug industry's biggest investor conference


There's something missing from one of the largest healthcare investor meetings of the year


CSL gets approval in Europe for its new haemophilia treatment


The biggest healthcare investor conference is happening next week -- here are the 5 things we expect to get out of it


An Australian biotech has applied to patent the world’s first low-GI sugar


Sirtex CEO goes on leave while his share trading is investigated


Sirtex shares are being crushed


Shares in medical cannabis company Zelda are going nuts


What we know so far about what a Trump presidency means for the drug industry


A pharma giant just made a $100 million move into a disease that's been called 'one of the next epidemic-level chronic diseases'